Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII

Lachlan J Smith1, Guilherme Baldo, Susan Wu

  • 1Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. lachlans@mail.med.upenn.edu

Insights

Mucopolysaccharidosis type VII (MPS VII) involves GAG accumulation and spine issues. Upregulated cathepsins and altered collagen II in MPS VII dogs suggest protease inhibition may treat spine disease.

Area of Science:

  • Biochemistry
  • Genetics
  • Orthopedics

Background:

  • Mucopolysaccharidosis type VII (MPS VII) results from beta-glucuronidase deficiency, causing glycosaminoglycan (GAG) buildup and multisystemic disease.
  • Spinal complications in MPS VII include kyphoscoliosis and cord compression due to intervertebral disk and vertebral body abnormalities.
  • Pathophysiological mechanisms for spinal changes in MPS VII remain unclear, though GAG binding to Toll-like receptor 4 (TLR4) is a potential factor.

Purpose of the Study:

  • Investigate the role of destructive proteases, specifically cathepsins, in spinal pathogenesis of MPS VII.
  • Examine the expression of cathepsins, TLR4, and collagen II in MPS VII canine spines.
  • Correlate findings in MPS VII dogs with human MPS VII spinal pathology.

Main Methods:

  • Assessed cathepsin B and K activity in the annulus fibrosus of MPS VII dog intervertebral disks.
  • Quantified mRNA levels for cathepsins, TLR4, and collagen II in MPS VII dog spinal tissues.
  • Examined spinal autopsy tissue from a human MPS VII patient for comparative analysis.

Main Results:

  • MPS VII dog intervertebral disks showed significantly elevated cathepsin B (117-fold) and cathepsin K (2-fold) activities.
  • Elevated mRNA levels for cathepsins and TLR4 were observed in the annulus fibrosus of MPS VII dogs.
  • MPS VII dogs exhibited increased collagen II mRNA in epiphyses, indicating delayed cartilage-to-bone conversion.
  • Human MPS VII spine showed similar cartilage accumulation and vertebral abnormalities.

Conclusions:

  • Spine disease in MPS VII may involve the upregulation of destructive proteases like cathepsins.
  • The findings suggest a potential role for GAG accumulation and TLR4 in MPS VII spinal pathology.
  • Inhibiting cathepsins could be a therapeutic strategy for reducing spinal disease in MPS VII patients.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Degenerative Disc Disease ll: Pathophysiology01:23

Degenerative Disc Disease ll: Pathophysiology

The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...